News/ News/ Oncology Epsilogen licenses first-in-class IgE ovarian cancer drug Phil Taylor antibody, Epsilogen, IgE, immuno-oncology, Oncology, ovarian cancer 0 Comment UK biotech Epsilogen has licensed rights to a drug for solid tumours developed by Kings College London and Share X Epsilogen licenses first-in-class IgE ovarian cancer drug https://pharmaphorum.com/news/epsilogen-licenses-first-in-class-ige-ovarian-cancer-drug/
antibody, Epsilogen, IgE, immuno-oncology, Oncology, ovarian cancer
0 Comment
